171 related articles for article (PubMed ID: 28257846)
1. 25-hydroxycholesterol promotes RANKL-induced osteoclastogenesis through coordinating NFATc1 and Sp1 complex in the transcription of miR-139-5p.
Zhang L; Lv Y; Xian G; Lin Y
Biochem Biophys Res Commun; 2017 Apr; 485(4):736-741. PubMed ID: 28257846
[TBL] [Abstract][Full Text] [Related]
2. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
3. Cooperation of PU.1 With IRF8 and NFATc1 Defines Chromatin Landscapes During RANKL-Induced Osteoclastogenesis.
Izawa N; Kurotaki D; Nomura S; Fujita T; Omata Y; Yasui T; Hirose J; Matsumoto T; Saito T; Kadono Y; Okada H; Miyamoto T; Tamura T; Aburatani H; Tanaka S
J Bone Miner Res; 2019 Jun; 34(6):1143-1154. PubMed ID: 30721543
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of requirement of receptor activator of nuclear factor κB signaling for interleukin 1-mediated osteoclastogenesis.
Jules J; Zhang P; Ashley JW; Wei S; Shi Z; Liu J; Michalek SM; Feng X
J Biol Chem; 2012 May; 287(19):15728-38. PubMed ID: 22416138
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-124 regulates osteoclast differentiation.
Lee Y; Kim HJ; Park CK; Kim YG; Lee HJ; Kim JY; Kim HH
Bone; 2013 Oct; 56(2):383-9. PubMed ID: 23867221
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
[TBL] [Abstract][Full Text] [Related]
7. Homer2 and Homer3 modulate RANKL-induced NFATc1 signaling in osteoclastogenesis and bone metabolism.
Son A; Kang N; Oh SY; Kim KW; Muallem S; Yang YM; Shin DM
J Endocrinol; 2019 Sep; 242(3):241-249. PubMed ID: 31319381
[TBL] [Abstract][Full Text] [Related]
8. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.
Kim JM; Lee JH; Lee GS; Noh EM; Song HK; Gu DR; Kim SC; Lee SH; Kwon KB; Lee YR
BMC Complement Altern Med; 2017 Mar; 17(1):164. PubMed ID: 28335757
[TBL] [Abstract][Full Text] [Related]
9. TGFβ1 Regulates Human RANKL-Induced Osteoclastogenesis via Suppression of NFATc1 Expression.
Tokunaga T; Mokuda S; Kohno H; Yukawa K; Kuranobu T; Oi K; Yoshida Y; Hirata S; Sugiyama E
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991837
[TBL] [Abstract][Full Text] [Related]
10. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
11. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
Jin G; Wang FF; Li T; Jia DD; Shen Y; Xu HC
Med Sci Monit; 2018 Apr; 24():2569-2577. PubMed ID: 29698379
[TBL] [Abstract][Full Text] [Related]
12. Effects of pulsed electromagnetic fields on the expression of NFATc1 and CAII in mouse osteoclast-like cells.
He J; Zhang Y; Chen J; Zheng S; Huang H; Dong X
Aging Clin Exp Res; 2015 Feb; 27(1):13-9. PubMed ID: 24869857
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-124 inhibits TNF-α- and IL-6-induced osteoclastogenesis.
Ohnuma K; Kasagi S; Uto K; Noguchi Y; Nakamachi Y; Saegusa J; Kawano S
Rheumatol Int; 2019 Apr; 39(4):689-695. PubMed ID: 30547186
[TBL] [Abstract][Full Text] [Related]
14. Arctigenin inhibits osteoclast differentiation and function by suppressing both calcineurin-dependent and osteoblastic cell-dependent NFATc1 pathways.
Yamashita T; Uehara S; Udagawa N; Li F; Kadota S; Esumi H; Kobayashi Y; Takahashi N
PLoS One; 2014; 9(1):e85878. PubMed ID: 24465763
[TBL] [Abstract][Full Text] [Related]
15. 27-Hydroxycholesterol enhanced osteoclastogenesis in lung adenocarcinoma microenvironment.
Zhang L; Liu M; Liu J; Li X; Yang M; Su B; Lin Y
J Cell Physiol; 2019 Aug; 234(8):12692-12700. PubMed ID: 30511368
[TBL] [Abstract][Full Text] [Related]
16. Docosahexaenoic acid signaling attenuates the proliferation and differentiation of bone marrow-derived osteoclast precursors and promotes apoptosis in mature osteoclasts.
Kim HJ; Ohk B; Yoon HJ; Kang WY; Seong SJ; Kim SY; Yoon YR
Cell Signal; 2017 Jan; 29():226-232. PubMed ID: 27836739
[TBL] [Abstract][Full Text] [Related]
17. Receptor activator of nuclear factor-kappaB ligand-induced nuclear factor of activated T cells (C1) autoregulates its own expression in osteoclasts and mediates the up-regulation of tartrate-resistant acid phosphatase.
Fretz JA; Shevde NK; Singh S; Darnay BG; Pike JW
Mol Endocrinol; 2008 Mar; 22(3):737-50. PubMed ID: 18063694
[TBL] [Abstract][Full Text] [Related]
18. miR-506-3p alleviates uncontrolled osteoclastogenesis via repression of RANKL/NFATc1 signaling pathway.
Dinesh P; Kalaiselvan S; Sujitha S; Rasool M
J Cell Physiol; 2020 Dec; 235(12):9497-9509. PubMed ID: 32372426
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB.
Koide N; Kondo Y; Odkhuu E; Ulziisaikhan J; Ukaji T; Yokochi T; Umezawa K
Immunol Lett; 2014 Sep; 161(1):31-7. PubMed ID: 24792671
[TBL] [Abstract][Full Text] [Related]
20. miR-31 controls osteoclast formation and bone resorption by targeting RhoA.
Mizoguchi F; Murakami Y; Saito T; Miyasaka N; Kohsaka H
Arthritis Res Ther; 2013; 15(5):R102. PubMed ID: 24004633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
